J Clin Microbiol. 1978 February; 7(2): 153-157
Hemolytic mutants of group A Streptococcus pyogenes.
W Owens,
F Henley and
B D Barridge
ABSTRACT
Hemolytic mutants of Lancefield strain SS-95 and ATCC 19615 Streptococcus pyogenes were produced by treatment with N-methyl-N'-nitro-N-nitrosoguanidine. These mutants contained the same levels of streptolysin O, nicotinamide adenine dinucleotidase, deoxyribonuclease, and hyaluronidase. The mutants were deficient in streptolysin S, as was the naturally occurring nonhemolytic Lowry strain. The mutants retained their pathogenicity for mice and, when reisolated from the dead animals, produced the mutant hemolytic pattern.
J Clin Microbiol. 1978 February; 7(2): 153-157
This article has been cited by other articles:
-
Fontaine, M. C., Lee, J. J., Kehoe, M. A.
(2003). Combined Contributions of Streptolysin O and Streptolysin S to Virulence of Serotype M5 Streptococcus pyogenes Strain Manfredo. Infect. Immun.
71: 3857-3865
[Abstract]
[Full Text]
-
Heath, A., DiRita, V. J., Barg, N. L., Engleberg, N. C.
(1999). A Two-Component Regulatory System, CsrR-CsrS, Represses Expression of Three Streptococcus pyogenes Virulence Factors, Hyaluronic Acid Capsule, Streptolysin S, and Pyrogenic Exotoxin B. Infect. Immun.
67: 5298-5305
[Abstract]
[Full Text]
-
Betschel, S. D., Borgia, S. M., Barg, N. L., Low, D. E., De Azavedo, J. C. S.
(1998). Reduced Virulence of Group A Streptococcal Tn916 Mutants That Do Not Produce Streptolysin S. Infect. Immun.
66: 1671-1679
[Abstract]
[Full Text]
Copyright © 1978 by the American Society for Microbiology. All rights reserved.